Precision BioSciences, Inc.
DTIL
$6.30
$0.6311.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -737.98% | -1,069.52% | -561.16% | 20.54% | 111.69% |
| Total Depreciation and Amortization | -39.85% | -47.32% | -50.49% | -47.93% | -44.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 139.36% | 184.23% | 130.14% | -18.91% | -255.12% |
| Change in Net Operating Assets | 45.84% | 97.82% | 109.24% | 25.30% | -30.16% |
| Cash from Operations | -12.66% | -52.07% | 2.22% | 18.31% | 30.52% |
| Capital Expenditure | 66.00% | -28.35% | 57.38% | 85.02% | 87.23% |
| Sale of Property, Plant, and Equipment | 10.00% | -77.32% | -94.85% | -100.00% | -43.93% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,360.00% | -103.33% | -103.66% | -103.49% | -100.33% |
| Cash from Investing | -194.88% | -434.21% | -106.45% | -107.71% | -103.69% |
| Total Debt Issued | -- | -100.09% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 88.49% | -50.21% | -41.14% | -52.92% | 831.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 88.63% | -50.24% | -41.18% | -52.97% | 836.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 449.39% | -5,449.94% | -172.55% | -86.47% | 88.74% |